Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-06-29

FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Piramal Critical Care, Inc.)

View source ↗

Summary

FDA approved Piramal Critical Care's levothyroxine sodium as an original application (ANDA206163), providing a generic option for thyroid hormone replacement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

ORIG AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)